Adamantios (Adam) Mamais, PhD, is a cell biologist who has been working as a research fellow in the Laboratory of Neurogenetics, National Institute on Aging, since 2013. He currently studies LRRK2 -- a protein implicated in inherited Parkinson's disease (PD) -- and its activity and modifications using both in vivo and in vitro models to understand molecular events that underlie PD pathology. Dr. Mamais received training as a scientific officer at the Institute of Cancer Research and a PhD from the University College London (UCL) Institute of Neurology, UK. While working as a postdoctoral fellow at the Reta Lila Weston Institute of Neurological Studies, UCL, Dr. Mamais showed that LRRK2 is involved in the oxidative stress response, a mechanism that cells use to protect themselves from harmful effects of oxygen.